Related Experiment Video
Updated: Oct 11, 2025

13:45
Using a Pan-Viral Microarray Assay Virochip to Screen Clinical Samples for Viral Pathogens
Published on: April 27, 2011
19.1K
Digital Quantification of Human Viral RNA and DNA Using a Self-Digitization Chip
Jiasi Wang1, Jason E Kreutz1, Daniel T Chiu2
1Department of Chemistry, University of Washington, Seattle, WA, USA.
Methods in Molecular Biology (Clifton, N.J.)
|November 27, 2021
Summary
A new microfluidics-based self-digitization (SD) chip enables point-of-care nucleic acid quantification. This simple platform demonstrates clinical diagnostic capability for viral DNA and RNA detection with high accuracy.
Area of Science:
- Biotechnology
- Molecular Diagnostics
- Microfluidics
Background:
- Digital nucleic acid quantitation offers high sensitivity and specificity for pathogen detection.
- Droplet digital PCR (ddPCR) is advanced but limited in point-of-care applications due to complex instrumentation.
Purpose of the Study:
- To develop a simple, microfluidics-based self-digitization (SD) chip for point-of-care nucleic acid quantification.
- To demonstrate the clinical diagnostic capability of the SD chip for human viral DNA and RNA detection.
Main Methods:
- Utilized microfluidics-based self-digitization (SD) chips with varying well numbers and volumes.
- Employed isothermal methods for amplifying DNA and RNA targets.
- Determined sample concentration using fluorescence counts and Poisson distribution analysis.
Main Results:
- SD chips demonstrated clinical diagnostic capability for quantifying human viral DNA and RNA.
- Concentration measurements correlated strongly (R² = 0.99) with real-time PCR assays in the 0-100 molecules/μL range.
- The platform showed high sensitivity and specificity for nucleic acid quantification.
Conclusions:
- The microfluidics-based SD chip offers a simplified approach to point-of-care nucleic acid quantification.
- This technology has potential for clinical diagnostics, overcoming limitations of existing complex methods.
- The SD chip platform provides accurate and sensitive detection of viral nucleic acids at the point of care.

